Join
Live feed
·
INSIDERFilingvia Quantisnow
Kindred Biosciences, Inc. logo

SEC Form 4: Zhan Hangjun returned $594,830 worth of Common Stock to the company (64,306 units at $9.25), closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
KIN· Kindred Biosciences, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KIN (Kindred Biosciences, Inc.) and more on Quantisnow.